HB 1416Oklahoma

Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.

Passed House

Apr 1, 2025: Second Reading referred to Health and Human Services Committee then to Appropriations Committee

Follow this bill Ratifi